US Bancorp’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

US Bancorp’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-32	Closed	-$3K	–	3801
2019 Q3	$3K	Buy	+32	New	+$3.2K	﹤0.01%	3387
2019 Q1	–	Sell	-1,046	Closed	-$41K	–	3717
2018 Q4	$41K	Hold	1,046	–	–	﹤0.01%	2540
2018 Q3	$57K	Buy	1,046 +376	+56%	+$25.7K	﹤0.01%	2497
2018 Q2	$55K	Buy	+670	New	+$51.7K	﹤0.01%	2536
2016 Q4	–	Sell	-100	Closed	-$6K	–	3697
2016 Q3	$6K	Hold	100	–	–	﹤0.01%	3143
2016 Q2	$5K	Hold	100	–	–	﹤0.01%	3207
2016 Q1	$3K	Sell	100 -100	-50%	-$3.15K	﹤0.01%	3324
2015 Q4	$9K	Buy	+200	New	+$10.5K	﹤0.01%	3088

US Bancorp's ONCE Position: Q4 2019 in Review

US Bancorp sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 32 shares — an estimated $3K sold.

US Bancorp first reported a position in ONCE in Q4 2015 and held it in 8 quarters. The position peaked at $57K in Q3 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

US Bancorp reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
US Bancorp sold 32 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $3K.
US Bancorp first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 8 quarters.
US Bancorp's Spark Therapeutics, Inc. Common Stock position peaked at $57K in Q3 2018.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.